Fosamax, Alendronate Newswire

Fosamax, Alendronate Newswire

Comprehensive Real-Time News Feed for Fosamax, Alendronate (generic).

Results 1 - 20 of 54 in Fosamax, Alendronate (generic)

  1. New guidelines recommend evaluation of osteoporosis risk for all postmenopausal womenRead the original story w/Photo

    Wednesday Nov 30 | Medical News

    Osteoporosis is preventable and treatable, but only a small proportion of people at risk for fractures are evaluated and treated, according to new osteoporosis guidelines written by an expert panel headed by Loyola Medicine endocrinologist Pauline M. Camacho, MD, FACE. The guidelines recommend that all postmenopausal women aged 50 and older be evaluated for osteoporosis risk.

    Comment?

  2. Most people at risk for osteoporisis fractures are not evaluated and treatedRead the original story w/Photo

    Monday Nov 28 | PhysOrg Weblog

    Osteoporosis is preventable and treatable, but only a small proportion of people at risk for fractures are evaluated and treated, according to new osteoporosis guidelines written by an expert panel headed by Loyola Medicine endocrinologist Pauline M. Camacho, MD, FACE. The guidelines recommend that all postmenopausal women aged 50 and older be evaluated for osteoporosis risk.

    Comment?

  3. Most People at Risk for Osteoporisis Fractures Are Not Evaluated and TreatedRead the original story

    Monday Nov 28 | Newswise

    Osteoporosis is preventable and treatable, but only a small proportion of people at risk for fractures are evaluated and treated, according to new osteoporosis guidelines written by an expert panel headed by Loyola Medicine endocrinologist Pauline M. Camacho, MD, FACE. The guidelines recommend that all postmenopausal women aged 50 and older be evaluated for osteoporosis risk.

    Comment?

  4. Findings support bisphosphonate use in men with osteoporosisRead the original story w/Photo

    Wednesday Nov 16 | PhysOrg Weblog

    Bisphosphonates reduce the risk of vertebral, and possibly nonvertebral, fractures for men with osteoporosis, according to a review and meta-analysis published online Nov. 7 in the Journal of the American Geriatrics Society . Smita Nayak, M.D., from the Swedish Medical Center in Seattle, and Susan L. Greenspan, M.D., from the University of Pittsburgh, conducted a systematic literature review to identify clinical trials that evaluated the efficacy of osteoporosis treatment for adult men, as well as reported fracture outcomes.

    Comment?

  5. Lentivirus-mediated short hairpin RNA interference targeting...Read the original story w/Photo

    Oct 17, 2016 | BioMed Central

    Aseptic loosening is a significant impediment to joint implant longevity. Prosthetic wear particles are postulated to play a central role in the onset and progression of periprosthetic osteolysis, leading to aseptic loosening of the prosthesis.

    Comment?

  6. Lorenzo Bosisio Appointed CEO Of EffRxRead the original story

    Oct 10, 2016 | BioSpace

    "It has been a challenging and rewarding journey to bring EffRx to what it is today. I look forward to seeing further success and to leading EffRx through the next stage of its development" Lorenzo Bosisio has been appointed as Chief Executive Officer effective July 1st, 2016.

    Comment?

  7. Lorenzo Bosisio Appointed CEO of EffRx PharmaceuticalsRead the original story

    Oct 11, 2016 | Customer Interaction Solutions

    Lorenzo Bosisio has been appointed as Chief Executive Officer effective July 1st, 2016. Prior to his promotion to CEO, Mr. Bosisio served as Chief Commercial Officer since 2013.

    Comment?

  8. A story for those who pontificate about patient behaviorRead the original story w/Photo

    Oct 8, 2016 | Kevin, M.D.

    I was offered my choice of bisphosphonates after breaking my shoulder and ended up with a diagnosis of osteoporosis. I initially opted for Reclast, a drug that only requires one dose a year albeit by IV infusion.

    Comment?

  9. Rapid Increase in Patient Numbers to Push Global Osteoporosis Drugs Market to US $8.9 Bn by 2020Read the original story w/Photo

    Oct 7, 2016 | SBWire

    The global osteoporosis drugs market is expected to reach US$8.9 bn by the end of 2020. It was valued at US$8.4 bn in 2013 and is progressing at a CAGR of 1.2% within a forecast period from 2014 to 2020, as stated by TMR analysts.

    Comment?

  10. Restenosis Therapeutic Pipeline Market Review, H2 2016Read the original story

    Sep 26, 2016 | World News Report

    PUNE, INDIA, September 26, 2016 / EINPresswire.com / -- The report provides comprehensive information on the therapeutics under development for Restenosis , complete with analysis by stage of development, drug target, mechanism of action , route of administration and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    Comment?

  11. Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment.Read the original story

    Sep 19, 2016 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Osteoporosis, characterized by loss of bone strength leading to fragility fractures, is a common event in patients who have primary biliary cirrhosis.

    Comment?

  12. Medical savings in PBS changesRead the original story w/Photo

    Sep 4, 2016 | Central Western Daily

    ORANGE residents being treated for diabetes, gastric reflux or high blood pressure could be among millions of Australians paying less for medicines under changes to the Pharmaceutical Benefits Scheme . More than 2000 medicine brands treating common conditions will drop in price from October 1, under the changes announced by Health Minister Sussan Ley.

    Comment?

  13. New study on China Risedronate Sodium Market, 2010-2019 - market...Read the original story

    Aug 26, 2016 | Emailwire.com

    With the ageing population, China has become the country with the largest number of people suffering from osteoporosis which is the most severe disease second to cardiovascular diseases. A nationwide large-scale epidemiological survey has also shown that It is estimated that the number of osteoporosis patients and patients with low bone mass will rise to 280 million by 2020.

    Comment?

  14. Research focused on the China Sodium Ibandronate Market, 2010-2019 -...Read the original story

    Aug 26, 2016 | Emailwire.com

    Research focused on the China Sodium Ibandronate Market, 2010-2019 - Global Trends, Capacity, Generation, Investment Trends, Regulations and Company Profiles Bone metastasis is common in patients with advanced malignant tumor. According to the statistics, each year millions of tumor patients especially patients with breast cancer, prostate cancer and lung cancer suffer from bone metastasis around the world.

    Comment?

  15. Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for InvestorsRead the original story w/Photo

    Aug 23, 2016 | TheStreet.com

    To ensure that you have a comfortable retirement, you need to find those investments that are guaranteed to generate a steady stream of profits -- not just for the next 12 months, but long term. One way to find them is to focus on those making the most progress in battling chronic diseases.

    Comment?

  16. New osteoporosis drug offers hopeRead the original story w/Photo

    Aug 16, 2016 | Boston.com

    A large clinical trial of a new osteoporosis drug found that it stimulates bone growth and prevents fractures at least as well as the only other such drug on the market. The new drug, expected to win approval from federal regulators, would offer another much-needed treatment for some of the 10 million Americans, 80 percent of them women, who have a disease that weakens bones and often leads to years of pain, disability and early death.

    Comment?

  17. Osteoporosis, a disease with few treatment options, may soon have one moreRead the original story w/Photo

    Aug 16, 2016 | Fountain Valley View

    In an undated handout photo, a model of porous bone mass build up from a new drug for osteoporosis, made from a 3-D printer. A large clinical trial of a new osteoporosis drug found that it stimulates bone growth and prevents fractures at least as well as the only other such drug on the market, offering a much-needed treatment for some of the 10 million Americans, who have a disease.

    Comment?

  18. Osteoporosis, a disease with few treatments, may soon have one moreRead the original story w/Photo

    Aug 16, 2016 | Boston.com

    A large clinical trial of a new osteoporosis drug found that it stimulates bone growth and prevents fractures at least as well as the only other such drug on the market. The drug, expected to win approval from federal regulators, would offer another much-needed treatment for some of the 10 million Americans, 80 percent of them women, who have a disease that weakens bones and often leads to years of pain, disability, and early death.

    Comment?

  19. Mayo Clinic Q&A: osteoporosis treatments; gastric bypass and alcohol's effectsRead the original story w/Photo

    Aug 4, 2016 | St. Petersburg Times

    The bisphosphonate drugs I take for osteoporosis aren't working in my case. My doctor has suggested a few alternatives.

    Comment?

  20. [Pyrophosphate in medicine].Read the original story

    Aug 4, 2016 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. In all organisms from bacteria to humans, specific hydrolases--pyrophosphatases--hydrolyse inorganic pyrophosphate to phosphate.

    Comment?